Sage Journals: Discover world-class research

Open access

Review article

First published 2022

The need for a strategic therapeutic approach: multiple sclerosis in check

Hernan Inojosa, Undine Proschmann, Katja Akgün [...]

Sage Open Chronic Disease

Free access

Research article

First published 2012-9

Multiple sclerosis and pregnancy: experience from a nationwide database in Germany

Kerstin Hellwig, Aiden Haghikia, Milena Rockhoff [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2024-8

Significantly increasing multiple sclerosis prevalence in Australia from 2010 to 2021

Julie A Campbell, Steve Simpson-Yap, Bruce V Taylor [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2023-7

Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination

Safiya A Zaloum, Callum H Wood, Pooja Tank [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2026

Rethinking our strategies to develop disease-modifying therapies for Parkinson's: Time for combination therapies?

Paloma Fernandez, Rachel M Hughes, Helen Matthews [...]

Journal of Parkinson’s Disease

Retricted access

Research article

First published 2013-6

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis

Bruce AC Cree

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry

Melissa A Wright, Bradley J Barney, Skyler Peterson [...]

Journal of Child Neurology

Retricted access

Research article

First published 2022-12

Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions

Philipp Eisele, Matthias Wittayer, Claudia E Weber [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025-1

European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?

Jérôme de Seze, Chiara Zecca, Giovanni Castelnovo [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Review article

First published 2021

Health economics of disease-modifying therapy for multiple sclerosis in the United States

Daniel M. Hartung

Therapeutic Advances in Neurological Disorders

Search results